Every record from PeptideMeter · page 25
Runs dual-wavelength detection as standard and reports named related substances rather than totals only. Measured offset against the reference laboratory is -0.024 pp on 569 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2024-005486 | Selank | BCH | BCH-2407-M6783 | 2024-Q3 | 99.20 | 6.80 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004550 | Semaglutide | JEEP | JEEP-2405-D3060 | 2024-Q4 | 99.39 | 4.41 | 99.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004518 | BPC-157 | FGP | FGP-2407-A2105 | 2024-Q3 | 99.81 | 4.73 | 93.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004697 | Liraglutide | TFC | TFC-2406-V7696 | 2024-Q3 | 99.42 | 5.43 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2024-005197 | Retatrutide | SSA | SSA-2405-G6398 | 2024-Q3 | 97.85 | 6.86 | 95.8 | Supplier-supplied | 2 | FAIL |
| AX-2024-004417 | Epitalon | QSC | QSC-2403-Y8722 | 2024-Q3 | 99.93 | 6.13 | — | Supplier-supplied | 0 | FAIL |
| AX-2024-004610 | Enclomiphene citrate | TFC | TFC-2404-J4890 | 2024-Q3 | 99.93 | 3.88 | 94.6 | Supplier-supplied | 0 | FAIL |
| AX-2024-004887 | Retatrutide | SWB | SWB-2402-V6189 | 2024-Q3 | 99.60 | 3.56 | 106.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004978 | Semaglutide | GGPeps | GGPE-2408-Y9789 | 2024-Q3 | 97.52 | 6.66 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2024-005142 | Selank | KP | KP-2405-H5398 | 2024-Q3 | 97.79 | 7.79 | 105.9 | Supplier-supplied | 0 | FAIL |
| AX-2024-004418 | Epitalon | QSC | QSC-2403-Y8722 | 2024-Q3 | 99.70 | 6.38 | — | Supplier-supplied | 0 | FAIL |
| AX-2024-005122 | Semaglutide | KP | KP-2405-C4384 | 2024-Q3 | 97.34 | 5.17 | 106.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004520 | BPC-157 | FGP | FGP-2407-A2105 | 2024-Q3 | 99.62 | 4.72 | 89.8 | Supplier-supplied | 3 | MARGINAL |
| AX-2024-004351 | Semaglutide | QSC | QSC-2408-D7316 | 2024-Q3 | 98.81 | 3.20 | 89.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-005193 | Retatrutide | SSA | SSA-2405-G6398 | 2024-Q3 | 97.20 | 6.33 | 99.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004395 | MOTS-c | QSC | QSC-2402-U8375 | 2024-Q3 | 99.42 | 2.98 | 93.8 | Laboratory-retained | 0 | PASS |
| AX-2024-005542 | NAD+ | QST | QST-2402-B8115 | 2024-Q3 | 97.66 | 8.82 | 104.3 | Buyer-sourced | 0 | PASS |
| AX-2024-004997 | Retatrutide | GGPeps | GGPE-2404-K1160 | 2024-Q3 | 97.50 | 4.92 | 106.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004688 | TB-500 | TFC | TFC-2405-J8155 | 2024-Q3 | 98.98 | 1.54 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2024-005256 | Ipamorelin | SSA | SSA-2404-U7946 | 2024-Q3 | 98.30 | 4.40 | 93.5 | Supplier-supplied | 2 | FAIL |
| AX-2024-005103 | Pramlintide | MKM | MKM-2405-U4415 | 2024-Q3 | 98.24 | 4.35 | 93.5 | Buyer-sourced | 0 | PASS |
| AX-2024-005061 | PT-141 (Bremelanotide) | MKM | MKM-2404-E2618 | 2024-Q3 | 99.93 | 4.64 | — | Supplier-supplied | 0 | PASS |
| AX-2024-005098 | Pramlintide | MKM | MKM-2405-U4415 | 2024-Q3 | 98.79 | 4.20 | 94.5 | Supplier-supplied | 0 | PASS |
| AX-2024-005088 | BPC-157 | MKM | MKM-2408-G3680 | 2024-Q3 | 98.94 | 5.53 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004995 | Retatrutide | GGPeps | GGPE-2404-K1160 | 2024-Q3 | 97.76 | 4.59 | 98.3 | Supplier-supplied | 2 | FAIL |
| AX-2024-004947 | Semaglutide | ERP | ERP-2404-Y7646 | 2024-Q3 | 98.78 | 3.39 | 96.9 | Supplier-supplied | 3 | MARGINAL |
| AX-2024-005290 | Semax | GL Biochem | GLBI-2404-U8654 | 2024-Q3 | 98.90 | 7.66 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2024-005225 | Glucagon | SSA | SSA-2408-F7210 | 2024-Q3 | 98.91 | 7.90 | 103.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004940 | Semaglutide | ERP | ERP-2404-Y7646 | 2024-Q3 | 99.29 | 4.02 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2024-004398 | MOTS-c | QSC | QSC-2402-U8375 | 2024-Q3 | 99.93 | 2.95 | — | Supplier-supplied | 0 | PASS |
| AX-2024-004396 | MOTS-c | QSC | QSC-2402-U8375 | 2024-Q3 | 99.65 | 3.25 | 96.5 | Laboratory-retained | 0 | PASS |
| AX-2024-004917 | Ipamorelin | ERP | ERP-2408-G7213 | 2024-Q3 | 99.93 | 4.46 | — | Supplier-supplied | 0 | PASS |
| AX-2024-004822 | Retatrutide | Homopeptide | HOMO-2407-P1771 | 2024-Q3 | 98.98 | 6.00 | 93.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004742 | Retatrutide | Homopeptide | HOMO-2405-B9038 | 2024-Q3 | 97.41 | 6.39 | 103.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004167 | Tirzepatide | WWB | WWB-2403-J3152 | 2024-Q3 | 98.51 | 3.64 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004438 | Afamelanotide | QSC | QSC-2407-F9884 | 2024-Q3 | 99.67 | 2.64 | — | Supplier-supplied | 0 | PASS |
| AX-2024-004713 | Pramlintide | TFC | TFC-2403-Y7884 | 2024-Q3 | 98.44 | 4.78 | 96.9 | Supplier-supplied | 0 | PASS |
| AX-2024-004702 | Liraglutide | TFC | TFC-2406-V7696 | 2024-Q3 | 99.00 | 5.50 | 101.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004696 | Liraglutide | TFC | TFC-2406-V7696 | 2024-Q3 | 99.33 | 4.68 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004393 | MOTS-c | QSC | QSC-2402-U8375 | 2024-Q3 | 99.45 | 3.06 | — | Supplier-supplied | 0 | PASS |